Menu
Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
100 Nagog Park
Acton, Massachusetts 01720-3440
Phone: 19786007000
www.myomnipod.com
Insulet (PODD) Stock Rises on FDA Approval for New Indication
The company had encouraging news to impart about its leading insulin pump.
Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares
What''s Driving Insulet Corp''s Surprising 12% Stock Rally?
Insulet Corp. The post Insulet’s Omnipod 5 Automated Insulin Delivery System Receives FDA Clearance For Type 2 Diabetes appeared first on ForexTV .
WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) has just received the green light from the U.S. Food and Drug Administration for its groundbreaking SmartAdjust Omnipod 5 automated insulin delivery sys…
U.S. equities were little changed at midday with the market awaiting the key earnings report from Nvidia tomorrow.
WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) said that the U.S. Food and Drug Administration cleared the company''s Omnipod 5 automated insulin delivery system for people with Type 2 diabetes. It is…
Insulet (PODD) said it has received FDA clearance for its Omnipod 5 Automated Insulin Delivery System for type 2 diabetes management in adults. Read more here.
Insulet (Nasdaq:PODD) announced today that the FDA cleared its Omnipod 5 automated insulin delivery for use by people with type 2 diabetes. Clearance makes Omnipod 5, the company’s latest-generation AID system, the first and only such system cleared for type 1 and type 2 diabetes. Its indication covers those ages 18 and older in the […] The post FDA clears Insulet Omnipod 5 for people with type 2 diabetes appeared first on Drug Delivery Business .